Medirom Inventory from 2010 to 2026

MRM Stock  USD 1.33  0.03  2.21%   
Medirom Healthcare Inventory yearly trend continues to be very stable with very little volatility. Inventory is likely to grow to about 183.1 M this year. During the period from 2010 to 2026, Medirom Healthcare Inventory quarterly data regression pattern had sample variance of 4847.3 T and median of  6,403,000. View All Fundamentals
 
Inventory  
First Reported
2018-12-31
Previous Quarter
151.6 M
Current Value
1.2 M
Quarterly Volatility
72.4 M
 
Covid
 
Interest Hikes
Check Medirom Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medirom Healthcare's main balance sheet or income statement drivers, such as Interest Income of 8.7 K, Depreciation And Amortization of 350.2 M or Interest Expense of 60.1 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.84. Medirom financial statements analysis is a perfect complement when working with Medirom Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Medirom Stock
Check out the analysis of Medirom Healthcare Correlation against competitors.
Evaluating Medirom Healthcare's Inventory across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Medirom Healthcare Technologies's fundamental strength.

Latest Medirom Healthcare's Inventory Growth Pattern

Below is the plot of the Inventory of Medirom Healthcare Technologies over the last few years. It is Medirom Healthcare's Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medirom Healthcare's overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Slightly volatile
   Inventory   
       Timeline  

Medirom Inventory Regression Statistics

Arithmetic Mean50,177,013
Geometric Mean17,330,247
Coefficient Of Variation138.75
Mean Deviation60,273,784
Median6,403,000
Standard Deviation69,622,241
Sample Variance4847.3T
Range177.6M
R-Value0.82
Mean Square Error1714.9T
R-Squared0.67
Significance0.000061
Slope11,271,283
Total Sum of Squares77556.1T

Medirom Inventory History

2026183.1 M
2025174.4 M
2024151.6 M
2023140 M
2022114.1 M
202118.7 M
2020M

Other Fundumenentals of Medirom Healthcare

About Medirom Healthcare Financial Statements

Medirom Healthcare investors utilize fundamental indicators, such as Inventory, to predict how Medirom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Inventory174.4 M183.1 M
Change To Inventory-9.6 M-10 M
Inventory Turnover 45.90  43.61 
Days Of Inventory On Hand 8.23  8.64 
Days Of Inventory Outstanding 8.23  8.64 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out the analysis of Medirom Healthcare Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Will Health Care Providers & Services sector continue expanding? Could Medirom diversify its offerings? Factors like these will boost the valuation of Medirom Healthcare. Expected growth trajectory for Medirom significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Medirom Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.278
Earnings Share
0.39
Revenue Per Share
1.2 K
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.02)
Understanding Medirom Healthcare requires distinguishing between market price and book value, where the latter reflects Medirom's accounting equity. The concept of intrinsic value - what Medirom Healthcare's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Medirom Healthcare's price substantially above or below its fundamental value.
Understanding that Medirom Healthcare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medirom Healthcare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medirom Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.